Medpace Holdings, Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Medpace Holdings, Inc. (MEDP) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $1.65 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-02-10
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2024-12-31 was $2.30M, a 318.00% increase year-over-year.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2024-09-30 was -$851.00K.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2024-06-30 was -$1.81M.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2024-03-31 was $5.34M, a 25.93% decline year-over-year.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $1.65M, a 66.99% decline from fiscal 2024.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $4.98M, a 5.14% decline from fiscal 2023.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $5.25M, a 32.97% decline from fiscal 2022.
- Medpace Holdings, Inc. noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $7.84M, a 23.39% increase from fiscal 2021.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.65M 10-K · filed 2026-02-10 | |||
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.45M derived: sum of 2 quarters · filed 2026-02-10 | -$361.00K derived: sum of 3 quarters · filed 2026-02-10 | $4.98M 10-K · filed 2026-02-10 |
| 2024-09-30 | -$851.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$2.66M derived: sum of 2 quarters · filed 2024-10-22 | $2.69M 10-Q · filed 2024-10-22 | $3.23M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | $3.54M 10-Q · filed 2024-07-23 | $4.09M derived: sum of 3 quarters · filed 2026-02-10 | $2.94M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $5.34M 10-Q · filed 2024-04-23 | $5.89M derived: sum of 2 quarters · filed 2026-02-10 | $4.75M derived: sum of 3 quarters · filed 2026-02-10 | $3.38M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$594.00K derived: sum of 2 quarters · filed 2026-02-10 | -$1.96M derived: sum of 3 quarters · filed 2026-02-10 | $5.25M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$2.51M derived: sum of 2 quarters · filed 2024-10-22 | $4.70M 10-Q · filed 2024-10-22 | $3.45M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | $5.85M 10-Q · filed 2024-07-23 | $4.59M derived: sum of 3 quarters · filed 2025-02-11 | $6.25M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $7.22M 10-Q · filed 2024-04-23 | $5.96M derived: sum of 2 quarters · filed 2025-02-11 | $7.61M derived: sum of 3 quarters · filed 2025-02-11 | $7.68M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $397.00K derived: sum of 2 quarters · filed 2025-02-11 | $463.00K derived: sum of 3 quarters · filed 2025-02-11 | $7.84M 10-K · filed 2025-02-11 |
| 2022-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | $1.72M derived: sum of 2 quarters · filed 2023-10-24 | $9.09M 10-Q · filed 2023-10-24 | $10.02M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $7.44M 10-Q · filed 2023-07-25 | $8.37M derived: sum of 3 quarters · filed 2024-02-13 | $7.97M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $7.38M 10-Q · filed 2023-04-25 | $8.30M derived: sum of 2 quarters · filed 2024-02-13 | $7.90M derived: sum of 3 quarters · filed 2024-02-13 | $7.20M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $928.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $528.00K derived: sum of 2 quarters · filed 2024-02-13 | -$179.00K derived: sum of 3 quarters · filed 2024-02-13 | $6.35M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$1.11M derived: sum of 2 quarters · filed 2022-10-25 | $5.42M 10-Q · filed 2022-10-25 | $13.67M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$707.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | $5.82M 10-Q · filed 2022-07-26 | $14.07M derived: sum of 3 quarters · filed 2023-02-14 | $13.11M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $6.53M 10-Q · filed 2022-04-26 | $14.78M derived: sum of 2 quarters · filed 2023-02-14 | $13.81M derived: sum of 3 quarters · filed 2023-02-14 | |
| 2020-12-31 | $8.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $7.28M derived: sum of 2 quarters · filed 2023-02-14 | $18.98M 10-K · filed 2023-02-14 | |
| 2020-09-30 | -$965.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | $10.73M 10-Q · filed 2021-10-26 | ||
| 2020-06-30 | $11.70M 10-Q · filed 2021-07-27 | |||
| 2019-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $362.00K derived: sum of 2 quarters · filed 2022-02-15 | $2.53M 10-K · filed 2022-02-15 | |
| 2019-09-30 | $693.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $2.86M 10-Q · filed 2020-10-27 | ||
| 2019-06-30 | $2.17M 10-Q · filed 2020-07-28 | |||
| 2018-12-31 | $1.55M 10-K · filed 2021-02-16 | |||
| 2017-12-31 | $678.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $1.69M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $176.00K 10-K · filed 2018-02-27 | |||
| 2014-12-31 | $153.00K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |